Literature DB >> 9559831

Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.

I Garcia-Bermejo, J Cacho, B Orden, J I Alós, J L Gómez-Garcés.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559831      PMCID: PMC105590          DOI: 10.1128/AAC.42.4.989

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Erythromycin resistance in streptococci.

Authors:  E Perez Trallero; J M Garcia Arenzana; M Urbieta Egaña
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

2.  Drug resistance in Streptococcus pyogenes isolated in Japan.

Authors:  M Nakae; T Murai; Y Kaneko; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.

Authors:  C Betriu; A Sanchez; M Gomez; A Cruceyra; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

5.  Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologie.

Authors:  C J Soussy; R Cluzel; P Courvalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

6.  [Antibiotic sensitivity of strains of group A beta-hemolytic streptococci isolated recently].

Authors:  J I Alós; R González-Palacios; J A Cuadros; J C Escobar
Journal:  Med Clin (Barc)       Date:  1990-01-13       Impact factor: 1.725

7.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

8.  In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.

Authors:  K M Coonan; E L Kaplan
Journal:  Pediatr Infect Dis J       Date:  1994-07       Impact factor: 2.129

9.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  9 in total
  7 in total

1.  Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.

Authors:  J A Jacobs; G J van Baar; N H London; J H Tjhie; L M Schouls; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 3.  Community acquired infections and bacterial resistance.

Authors:  H Goossens; M J Sprenger
Journal:  BMJ       Date:  1998-09-05

4.  Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J G de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 5.  Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.

Authors:  E Perez-Trallero; J M Marimón; M Montes; B Orden; M de Pablos
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

6.  Erythromycin resistance in Streptococcus pyogenes in Italy.

Authors:  M Bassetti; G Manno; A Collidà; A Ferrando; G Gatti; E Ugolotti; M Cruciani; D Bassetti
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

Review 7.  [Patient consent to "antimicrobial treatment of tonsillitis"].

Authors:  C Cenjor; J A García-Rodríguez; A Ramos; J Cervera; M Tomás; F Asensi; J L Cañada; M Gobernado; T Isasiá; C López-Madroñero; M Martínez; F Pérez-Escanilla; J Picazo; J Prieto; T Sampelayo
Journal:  Acta Otorrinolaringol Esp       Date:  2003-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.